查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853860

全球單光子發射電腦斷層掃描市場（檢測器、最終用戶、產品和應用分類）—2025-2032年全球預測

Single Photon Emission Computed Tomography Market by Detector, End User, Product, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，單光子發射電腦斷層掃描市場規模將達到 30.2 億美元，複合年成長率為 4.08%。

主要市場統計數據
基準年 2024 21.9億美元
預計年份：2025年 22.8億美元
預測年份：2032年 30.2億美元
複合年成長率 (%) 4.08%

本文簡要介紹了SPECT的現狀，重點闡述了其臨床可靠性、技術變革以及診斷閱片者的採購注意事項。

單光子發射電腦斷層掃描（SPECT）仍然是核子醫學的基石技術，它在循環系統、神經科和腫瘤學領域具有廣泛的臨床效用和功能成像能力。過去十年來的技術發展使該技術從類比檢測器架構過渡到數位和半導體架構，從而提高了計數靈敏度、空間解析度和工作流程整合度。這些進步與臨床實踐的變化同步發生，並影響放射性藥物的物流、成像方案以及診斷中心和醫院系統的設備更新換代週期。

臨床醫生仍依賴SPECT進行心肌灌注顯像、腦灌注評估以及標靶腫瘤學研究，在這些研究中，基於代謝和受體的顯像可以與解剖學方法形成互補。隨著醫療系統優先考慮以金額為準和診斷效率，SPECT憑藉其多樣化的檢測器技術和模組化產品配置，能夠適應各種臨床應用場景，從大型心臟病實驗室到專業研究機構均可適用。因此，採購負責人和影像處理管理人員在規劃設備升級或新購置時，必須考慮臨床需求、機構吞吐量和生命週期成本。

從既有實踐向創新主導的過渡，需要將技術性能與臨床通訊協定進行精細匹配。因此，相關人員應檢測器。

SPECT成像中檢測器的突破、人工智慧重建技術的應用以及不斷發展的臨床工作流程，正在重新定義診斷預期和籌資策略。

由於檢測器的創新、軟體智慧化以及臨床工作流程的改變，SPECT領域正在經歷顯著的變化。新型檢測器技術正推動系統從笨重的碘化鈉晶體向緊湊的碲化鎘鋅和先進的固體感測器過渡，這些感測器具有固有的能量解析度和更短的死時間。同時，影像重建演算法和人工智慧驅動的後處理正在增強病灶的檢測和定量能力，從而改變人們對診斷準確性和報告時間的預期。

臨床醫生擴大將功能性SPECT數據與CT衍生的衰減校正和解剖學關聯相結合，以提高診斷的準確性。同時，醫療服務模式的轉變，例如門診影像的整合和心臟影像專科中心的激增，正促使採購重點轉向兼顧吞吐量和成本效益的系統。不斷變化的供應鏈動態和監管環境也推動製造商和用戶尋求多樣化的籌資策略和模組化升級方案。

挑戰主要體現在兩個方面：一是提升臨床效用和以病人為中心的工作流程的機會；二是技術選擇與長期耐受性、放射性藥物供應以及不斷變化的報銷模式之間複雜協調的難題。因此，策略規劃必須兼顧技術的快速發展與永續的營運模式。

評估累積關稅如何重塑SPECT設備製造商和醫療保健提供者的供應鏈、採購時間表和籌資策略

美國近期加徵的關稅加劇了全球醫療設備供應鏈的敏感性，對SPECT系統製造商、經銷商和終端用戶都產生了累積影響。半導體檢測器、精密機械零件和專用電子元件等組件的成本易受關稅影響而上漲，這可能導致醫院和診斷中心的土地購置成本增加，並使資本採購週期更加複雜。為此，製造商正在重新評估其採購佈局和供應契約，以在確保產品供應的同時降低風險。

因此，許多供應商正在加快關鍵零件的在地化進程，與替代供應商建立合作關係，並調整物流策略以降低關稅風險。此類調整通常涉及將組裝業務轉移到近岸地區、重新談判供應商條款以及重新設計產品架構以使用更容易購買的子系統。採購團隊則透過延長資本項目的前置作業時間，並將供應商的穩定性和長期服務協議置於短期價格優勢之上來應對這些變化。

從營運角度來看，影像中心可能會面臨更長的採購週期和更高的購置成本，這將影響升級速度和高通量設備的優先部署。因此，臨床醫生和管理人員應將關稅相關的供應鏈不確定性納入資本規劃，以基於情境的採購藍圖取代組件供應穩定的假設。這些路線圖應強調靈活性、全生命週期服務支援以及針對投入成本波動的合約保障。

主導深度細分，將檢測器技術、終端用戶優先順序、產品架構和臨床應用與採購和臨床策略連結起來，從而獲得洞察。

對檢測器技術的細分揭示了臨床應用優先事項的明顯差異。碲化鎘鋅檢測器和先進的固體探測器，包括鍺半導體和矽光電倍增器，因其卓越的能量解析度和計數靈敏度而備受青睞，尤其適用於需要檢測弱電離離子的應用。相較之下，碘化鈉閃爍探測器因其成本效益和成熟的工作流程而廣泛應用，在許多進行大量成像的診斷中心仍然佔據一席之地。這些檢測器的差異不僅影響影像質量，也影響服務需求、培訓需求和資金分配決策。

終端使用者細分凸顯了診斷中心、醫院和研究機構在採購促進因素上的差異。診斷中心優先考慮吞吐量和單次掃描成本效率，通常傾向於工作流程簡化且可快速重新配置的系統。公立和私立醫院則需要在臨床多功能性和預算限制之間尋求平衡。私人醫院可能優先考慮高階檢測器和整合服務包以提升其競爭優勢，而公立醫院則往往更重視穩定的正常執行時間、標準化的通訊協定和長期維護協議。研發機構則更青睞可配置性和先進的檢測技術，以支援通訊協定開發和探索性應用。

產品配置也會影響購買決策。單探頭系統適用於空間受限或低容量環境；雙探頭儀器為普通心臟病學和腫瘤學應用提供均衡的吞吐量和靈活性；而當高靈敏度和快速採集至關重要時，則會選擇三探頭系統。應用領域細分為心臟病學、神經病學和腫瘤學，持續影響系統需求。心臟病學需要快速門控通訊協定，神經病學強調灌注定量，而腫瘤學則需要靶向示踪劑相容性和定量工作流程。這些細分層次決定了相關人員在選擇 SPECT 解決方案時必須協調的技術規格、服務模式和採集優先順序。

亞太地區、中東和非洲以及美洲的區域動態和採用模式對SPECT系統的採購、部署和維護能力產生影響。

區域動態對SPECT系統的應用模式與策略重點有顯著影響。美洲地區對先進心臟成像的需求高度集中，由此形成了一個強大的供應商生態系統，支持檢測器創新技術的快速臨床轉化。在該地區，私人影像中心和醫院網路通常優先考慮吞吐量和整合服務契約，這為模組化系統升級和高階檢測器的部署創造了有利條件。法規環境和報銷機制也進一步影響新技術在臨床實務中的評估和應用。

儘管高所得的歐洲市場正穩步採用先進的數位檢測器和混合工作流程，但中東和非洲市場的特點是投資選擇性地集中在三級醫院和專科中心。鑑於跨境零件供應的物流複雜性，這些地區通常優先考慮可靠性和長期可維護性。與此同時，亞太地區在不斷成長的中階醫療保健需求、對心臟病和影像處理中心的投資以及降低先進檢測器系統採購門檻的本地製造舉措的推動下，正在快速推進其影像基礎設施的現代化。

在每個地區，放射性藥物的供應、訓練系統和醫療政策重點等當地因素都會影響醫療機構如何決定升級和部署SPECT系統的優先順序。因此，區域策略必須整合臨床需求、供應鏈韌性和監管合規性，以最佳化部署並確保永續營運。

競爭格局、卓越服務以及硬體創新者和軟體開發商之間的夥伴關係如何塑造 SPECT 供應商格局

SPECT 生態系統的競爭主要由跨國影像設備製造商和專注於檢測器創新或特定臨床解決方案的專業公司組成。大型成熟的醫療影像公司利用其全球服務網路和一體化產品系列與醫療機構簽訂契約，並持續提供可預測的全生命週期支持；而規模較小的專業公司則憑藉尖端的檢測器技術、緊湊的外形尺寸或軟體主導的圖像增強功能脫穎而出。設備製造商和軟體開發商之間的夥伴關係日益重要，這使得重建演算法和人工智慧輔助診斷工具能夠不斷迭代更新。

能夠提供全面培訓專案、預測性維護和快速零件供應的供應商更有可能與醫院和診斷連鎖機構簽訂長期合約。此外，與放射性藥物供應商和臨床研究機構舉措，能夠促進多中心研究和方案標準化，從而增強供應商的價值提案。因此，資本設備採購委員會和影像科主管在評估供應商時，不僅會考慮設備性能，還會考慮整體擁有成本、升級途徑和已證實的臨床結果。

創新研發的重點在於檢測器小型化、能量閥改進以及提升定量報告的軟體平台。軟硬體的進步為新參與企業挑戰現有產品提供了途徑，而現有企業則透過收購、合作和內部研發項目來保持競爭力。最終，競爭成功取決於能否將技術差異化與可靠的服務模式以及臨床應用效果結合。

醫療保健主管和供應商在採用 SPECT 技術時，應採取切實可行的策略措施，協調採購、臨床效用和供應鏈彈性。

計劃投資SPECT技術的產業領導者應優先考慮模組化、供應鏈彈性和臨床應用相容性，以確保其資本決策面向未來。在選擇新系統時，決策者應要求提供靈活的升級路徑，以便在無需更換整個系統的情況下改進檢測器和軟體。籌資策略還應包括供應商多元化和合約保護，以降低關稅和地緣政治造成的供應中斷風險。

在臨床方面，各機構應將採購標準與高影響力應用相符。優先考慮那些能夠顯著提升心臟病學、神經病學或腫瘤學工作流程診斷信心，並能與PACS和報告基礎設施無縫整合的系統。投資於員工培訓和規範通訊協定，以提升先進檢測器和重建軟體的臨床價值，並確保影像處理效能的提升能轉化為病患管理的改善。在營運方面，應優先考慮全生命週期支援協議和備件物流，以最大限度地延長運作並確保可預測的營運成本。

最後，與產業夥伴合作進行先驅性研究和分階段推廣，可以降低推廣風險，同時獲得臨床和營運效益的本地證據。透過將靈活的技術規範與強大的服務框架和循證夥伴關係相結合，企業領導者可以確保其影像資產能夠持續提供臨床價值和營運韌性。

結合臨床醫師訪談、技術檢驗和二手文獻整合的嚴謹多方法研究途徑，確保了對SPECT技術的可靠和透明的見解。

本研究採用多方法結合的方式，融合了第一手資料、二手資料和技術檢驗。第一手資料包括對臨床終端使用者、影像物理學家、採購負責人和設備工程師進行結構化訪談，以了解他們對效能要求、操作挑戰和服務期望的現場觀點。此外，還諮詢了監管專家，以解讀核准管道和合規性問題對設備部署時間表的影響，從而補充了這些定性見解。

二次研究涵蓋了同行評審文獻、臨床指南、製造商技術規範以及公開的監管文件，旨在建立關於檢測器性能特徵、成像通訊協定和特定應用要求的可靠依證。盡可能透過參與機構提供的匿名採購案例和設備生命週期記錄進行定量最後覆核。在整個過程中，我們應用了資料檢驗技術，包括來源三角驗證、一致性檢查和專家小組審查，以確保分析的嚴謹性並減少潛在的偏差。

本調查方法強調透明度和可重複性，所有假設均有記錄，訪談資料均已存檔，並可根據新的臨床證據和技術發展對分析方法進行更新。相關人員希望了解調查方法或進行客製化分析，歡迎直接聯繫調查團隊進行專門檢驗。

影響SPECT實施成功及其長期臨床價值的技術、操作和策略因素概述

總而言之，SPECT仍然是一種重要且適應性強的顯像模式，其近期發展軌跡將取決於檢測器創新、軟體驅動的影像品質提升以及由營運優先順序和供應鏈動態動態驅動的採購模式轉變。積極將技術選擇與臨床應用案例相結合，並優先考慮模組化升級、完善的服務協議和循證實踐的相關人員，將更有利於把技術進步轉化為診斷信心和患者吞吐量方面的可衡量提升。

關稅相關的供應鏈中斷和區域差異凸顯了彈性籌資策略和基於情境的採購規劃的必要性。同時，競爭格局有利於那些將硬體差異化、可靠的售後支援以及在證據生成方面開展合作的供應商。隨著臨床界對更高解析度、更快採集速度和定量輸出的需求不斷成長，先進檢測器和智慧重建技術的結合將引領下一波SPECT應用浪潮。

對 SPECT 技術的投資應得到培訓、標準化方案和供應商關係的有力支持，以確保長期的臨床和財務永續性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到SPECT掃描中，以提高影像重建精度和診斷可靠性
  • 開發用於遠端心臟和神經系統評估的可攜式SPECT成像設備
  • 利用靶向神經發炎生物標記的新型放射性藥物追蹤劑來提高阿茲海默症早期檢測率
  • 擴展混合SPECT/CT影像系統，以實現腫瘤診斷中更精確的解剖定位
  • 在基於定量SPECT的放射性藥物治療計劃中，對個人化劑量測定通訊協定的需求日益成長。
  • 一種新型99mTc標記心肌灌注劑已獲得監管部門核准，用於改善慢性冠狀動脈疾病的治療
  • 實施雲端基礎的SPECT資料管理平台，以加強多中心協作研究和遠端醫療分析
  • 固體檢測器技術的進步將提高下一代SPECT相機的靈敏度和空間解析度。
  • 標準化定量軟體在利用SPECT進行帕金森氏症進展的可重複縱向監測的應用日益廣泛
  • 利用SPECT分子影像技術評估PSMA標靶放射性示蹤劑在前列腺癌分期中的臨床研究數量迅速增加。

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 單光子發射電腦斷層掃描市場（依檢測器）

  • CZT
  • NAI閃爍
  • 固態
    • 鍺半導體
    • 矽光電倍增器

9. 單光子發射電腦斷層掃描市場（依最終用戶分類）

  • 診斷中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究所

10. 單光子發射電腦斷層掃描市場（依產品分類）

  • 雙頭
  • 單頭
  • 三頭

第11章 單光子發射電腦斷層掃描市場（依應用領域分類）

  • 心臟病學
  • 神經病學
  • 腫瘤學

12. 單光子發射電腦斷層掃描市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 單光子發射電腦斷層掃描市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國單光子發射電腦斷層掃描市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Spectrum Dynamics Medical Ltd.
    • Digirad Corporation
    • Neusoft Medical Systems Co., Ltd.
    • Mediso Medical Imaging Systems Ltd.
    • Shimadzu Corporation
    • Hitachi, Ltd.
Product Code: MRR-02026C4CB810

The Single Photon Emission Computed Tomography Market is projected to grow by USD 3.02 billion at a CAGR of 4.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.19 billion
Estimated Year [2025] USD 2.28 billion
Forecast Year [2032] USD 3.02 billion
CAGR (%) 4.08%

A concise introduction to the current SPECT landscape highlighting clinical reliance, technological shifts, and procurement considerations for diagnostic leaders

Single Photon Emission Computed Tomography (SPECT) remains a cornerstone modality in nuclear medicine, combining functional imaging with widespread clinical utility across cardiology, neurology, and oncology. Technological evolution over the last decade has shifted the modality from analog detector paradigms toward digital and solid-state architectures, enabling improved count sensitivity, spatial resolution, and workflow integration. These advances are occurring in parallel with changes in radiopharmaceutical logistics, imaging protocols, and clinical pathways that collectively influence adoption and upgrade cycles in diagnostic centers and hospital systems.

Clinicians continue to rely on SPECT for myocardial perfusion imaging, brain perfusion assessments, and targeted oncologic studies where metabolic and receptor-based imaging complements anatomical techniques. As healthcare systems emphasize value-based outcomes and diagnostic efficiency, SPECT's adaptability-through diverse detector technologies and modular product configurations-supports a range of clinical use cases from high-volume cardiology labs to specialized research institutes. Consequently, procurement leaders and imaging directors must weigh clinical requirements, facility throughput, and lifecycle costs when planning equipment refreshes or new deployments.

Transitioning from established practice to innovation-led deployment requires careful alignment of technical performance with clinical protocols. Therefore, stakeholders should appraise detector options, head configurations, and service models in light of evolving clinical guidelines and operational priorities to ensure systems deliver measurable improvements in diagnostic confidence and patient throughput.

How detector breakthroughs, AI-driven reconstruction, and evolving clinical workflows are redefining diagnostic expectations and procurement strategies in SPECT imaging

The SPECT landscape is undergoing transformative shifts driven by convergence of detector innovation, software intelligence, and altered clinical workflows. New detector technologies are moving systems away from large-volume sodium iodide crystals toward compact cadmium zinc telluride and advanced solid-state sensors that offer intrinsic energy resolution and reduced dead time. Concurrently, image reconstruction algorithms and AI-enabled post-processing are enhancing lesion detectability and quantification, which is changing expectations for diagnostic accuracy and reporting timelines.

Operationally, hybrid imaging strategies and multimodality integration are reshaping how SPECT is positioned within diagnostic pathways; clinicians increasingly combine functional SPECT data with CT-derived attenuation correction and anatomical correlation, improving diagnostic confidence. At the same time, shifts in healthcare delivery-such as outpatient imaging consolidation and the proliferation of dedicated cardiac imaging centers-are altering procurement priorities toward systems that balance throughput with cost-efficiency. Supply chain dynamics and regulatory evolution are also prompting manufacturers and adopters to pursue diversified sourcing strategies and modular upgrade paths.

Taken together, these shifts create both opportunity and complexity: opportunities to enhance clinical utility and patient-centric workflows, and complexity in aligning technology selection with long-term serviceability, radiopharmaceutical availability, and evolving reimbursement models. Strategic planning must therefore reconcile rapid technological progress with sustainable operational models.

Assessing how cumulative tariff actions are reshaping supply chains, procurement timelines, and sourcing strategies for SPECT system manufacturers and healthcare providers

Recent tariff measures in the United States have introduced heightened sensitivity across global medical device supply chains, with cumulative implications for manufacturers, distributors, and end users of SPECT systems. Components such as semiconductor detectors, precision mechanical parts, and specialized electronics are vulnerable to tariff-induced cost pressures, which can increase landed costs and complicate capital procurement cycles for hospitals and diagnostic centers. In response, manufacturers are reassessing sourcing footprints and supply contracts to mitigate exposure while preserving product availability.

Consequently, many suppliers have accelerated localization of key components, established alternate supplier relationships, and adjusted logistics strategies to reduce tariff risk. These adaptations often entail nearshoring assembly operations, renegotiating supplier terms, and redesigning product architectures to use more readily sourced subsystems. Procurement teams are reacting by extending lead times in capital planning and prioritizing supplier stability and long-term service agreements over short-term price advantages.

From an operational standpoint, imaging centers may encounter longer procurement timelines and elevated acquisition costs that influence upgrade pacing and prioritization of high-throughput installations. Clinicians and administrators should therefore factor tariff-related supply chain uncertainty into capital planning, replacing assumptions of stable component availability with scenario-based procurement roadmaps that emphasize flexibility, lifecycle service support, and contractual protections against volatile input costs.

Deep segmentation-driven insights linking detector technologies, end-user priorities, product architectures, and clinical applications to procurement and clinical strategy

Detector technology segmentation reveals a clear divergence in clinical priorities: cadmium zinc telluride detectors and advanced solid-state options, including germanium semiconductors and silicon photomultipliers, are valued for superior energy resolution and count sensitivity, particularly in applications requiring small-lesion detection. By contrast, sodium iodide scintillation remains prevalent where cost efficiency and established workflows dominate, sustaining its presence in many diagnostic centers with large imaging volumes. These detector distinctions influence not only image quality but also service requirements, training needs, and capital allocation decisions.

End-user segmentation highlights differentiated procurement drivers across diagnostic centers, hospitals, and research institutes. Diagnostic centers prioritize throughput and cost-per-scan efficiency and therefore often favor systems with simplified workflows and rapid reconstruction. Hospitals, both private and public, balance clinical versatility with budgetary constraints; private hospitals may prioritize premium detectors and integrated service packages to support competitive positioning, whereas public hospitals frequently emphasize robust uptime, standardized protocols, and long-term maintenance contracts. Research institutes favor configurability and advanced detection technologies that enable protocol development and exploratory applications.

Product configuration also informs purchasing decisions: single-head systems appeal in space-constrained or low-volume settings, dual-head instruments offer balanced throughput and flexibility for general cardiology and oncology applications, and triple-head systems are selected where high sensitivity and faster acquisition are essential. Application segmentation into cardiology, neurology, and oncology continues to shape system requirements, with cardiology driving demand for rapid gated protocols, neurology emphasizing perfusion quantification, and oncology requiring compatibility with targeted tracers and quantitative workflows. Collectively, these segmentation layers determine the technical specifications, service models, and acquisition priorities that stakeholders must reconcile when selecting SPECT solutions.

Regional dynamics and adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, deployment, and serviceability of SPECT systems

Regional dynamics exert strong influence over adoption patterns and strategic priorities for SPECT systems, with the Americas exhibiting concentrated demand in advanced cardiac imaging and a robust vendor ecosystem that supports rapid clinical translation of detector innovations. In this region, private imaging centers and hospital networks often prioritize throughput and integrated service agreements, creating fertile ground for modular system upgrades and premium detector deployments. Regulatory environments and reimbursement frameworks further shape how new technologies are evaluated and adopted in clinical practice.

In Europe, the Middle East and Africa, the landscape is more heterogeneous; high-income European markets show steady uptake of advanced digital detectors and hybrid workflows, while markets across the Middle East and Africa are characterized by selective investments concentrated in tertiary hospitals and specialty centers. These geographies often emphasize reliability and long-term serviceability, given the logistical complexities of cross-border parts supply. Meanwhile, Asia-Pacific demonstrates rapid modernization in imaging infrastructure, driven by expanding middle-class healthcare demand, investment in specialized cardiac and oncologic centers, and local manufacturing initiatives that can lower acquisition barriers for advanced detector systems.

Across all regions, localized factors such as radiopharmaceutical availability, training ecosystems, and healthcare policy priorities shape how facilities prioritize upgrades and deploy SPECT systems. As a result, regional strategy must integrate clinical needs, supply chain resilience, and regulatory compliance to optimize deployment and ensure sustainable operations.

How competitive positioning, service excellence, and partnerships between hardware innovators and software developers are shaping the SPECT vendor landscape

Competitive dynamics in the SPECT ecosystem are governed by a mix of multinational imaging manufacturers and specialized firms that emphasize detector innovation or niche clinical solutions. Large, established medical imaging companies continue to leverage global service networks and integrated product portfolios to secure institutional contracts and deliver predictable lifecycle support, while smaller specialists differentiate through cutting-edge detector technologies, compact form factors, or software-driven image enhancement. Partnerships between device manufacturers and software developers are increasingly important, enabling iterative updates to reconstruction algorithms and AI-supported diagnostic aids.

Service and aftermarket support represent a decisive competitive axis: vendors that offer comprehensive training programs, predictive maintenance, and rapid parts availability tend to secure longer-term contracts with hospitals and diagnostic chains. Additionally, collaborative initiatives with radiopharmaceutical suppliers and clinical research organizations strengthen a supplier's value proposition by facilitating multi-center studies and protocol standardization. Capital equipment procurement committees and imaging directors therefore evaluate vendors not only on device performance but on the total cost of ownership, upgrade pathways, and demonstrated clinical outcomes.

Innovation pipelines focus on detector miniaturization, enhanced energy discrimination, and software platforms that improve quantitative reporting. This combination of hardware and software advancement provides new entrants with avenues to challenge incumbent offerings, while incumbents invest in acquisition, partnership, and internal R&D programs to maintain relevance. Ultimately, competitive success depends on aligning technical differentiation with dependable service models and evidence of clinical impact.

Actionable strategic imperatives for healthcare executives and vendors to align procurement, clinical utility, and supply chain resilience when adopting SPECT technologies

Industry leaders planning investments in SPECT technology should prioritize modularity, supply chain resilience, and clinical alignment to future-proof capital decisions. When specifying new systems, decision-makers should require flexible upgrade paths that allow detector or software improvements without full system replacement, thereby protecting capital while enabling performance enhancements as clinical needs evolve. Procurement strategies must also incorporate supplier diversification and contractual protections to mitigate tariff-driven and geopolitical supply disruptions.

Clinically, organizations should align acquisition criteria with high-impact applications: prioritize systems that demonstrably improve diagnostic confidence in cardiology, neurology, or oncology workflows and that integrate seamlessly with PACS and reporting infrastructures. Investing in staff training and protocol harmonization enhances the clinical value of advanced detectors and reconstruction software, ensuring that improved imaging performance translates into better patient management. From an operational perspective, emphasize total lifecycle support agreements and spare-part logistics to maximize uptime and predictable operating costs.

Finally, collaboration with industry partners on pilot studies and phased rollouts can de-risk adoption while generating local evidence of clinical and operational benefits. By combining flexible technical specifications with robust service frameworks and evidence-generating partnerships, leaders can secure imaging assets that deliver sustained clinical value and operational resilience.

A rigorous multi-method research approach combining clinician interviews, technical validation, and secondary literature synthesis to ensure reliable and transparent insights into SPECT technologies

This research was developed using a multi-method approach that triangulates primary stakeholder inputs with curated secondary sources and technical validation. Primary research included structured interviews with clinical end users, imaging physicists, procurement officers, and device engineers to capture frontline perspectives on performance requirements, operational challenges, and service expectations. These qualitative insights were supplemented by consultations with regulatory specialists to interpret approval pathways and compliance implications that affect device deployment timelines.

Secondary research encompassed peer-reviewed literature, clinical guidelines, manufacturer technical specifications, and publicly available regulatory filings to establish a robust evidence base on detector performance characteristics, imaging protocols, and application-specific requirements. Quantitative cross-checks were performed where feasible through anonymized procurement case studies and device lifecycle records provided by participating institutions. Throughout the process, data validation techniques such as source triangulation, consistency checks, and expert panel review were applied to ensure analytic rigor and mitigate potential bias.

The methodology emphasizes transparency and reproducibility: assumptions are documented, interview instruments are archived, and the analytical framework is designed to accommodate updates as new clinical evidence and technological developments emerge. Stakeholders seeking methodological clarification or bespoke analysis were invited to engage directly with the research team for tailored validation exercises.

Concluding synthesis of technological, operational, and strategic factors that will determine successful SPECT adoption and long-term clinical value

In conclusion, SPECT remains a vital and adaptable imaging modality whose near-term trajectory is defined by detector innovation, software-enabled image quality gains, and shifting procurement paradigms driven by operational priorities and supply chain dynamics. Stakeholders that proactively align technical selections with clinical use cases-prioritizing modular upgrades, robust service agreements, and evidence generation-will be best positioned to translate technological advances into measurable improvements in diagnostic confidence and patient throughput.

Tariff-related supply chain disruptions and regional heterogeneity underscore the need for flexible sourcing strategies and scenario-based procurement planning. Meanwhile, the competitive landscape rewards vendors that couple hardware differentiation with dependable aftermarket support and collaborative evidence-generation efforts. As the clinical community continues to demand higher resolution, faster acquisitions, and quantitative outputs, the combination of advanced detectors and intelligent reconstruction will shape the next wave of SPECT deployments.

Moving forward, organizations should balance innovation adoption with operational resilience, ensuring that investments in SPECT technology are underpinned by training, standardized protocols, and supplier relationships that support long-term clinical and financial sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms to enhance image reconstruction accuracy and diagnostic confidence in SPECT scans
  • 5.2. Development of portable SPECT imaging devices enabling point-of-care cardiac and neurological assessments in remote settings
  • 5.3. Adoption of novel radiopharmaceutical tracers targeting neuroinflammation biomarkers to improve early detection of Alzheimer's disease
  • 5.4. Expansion of hybrid SPECT/CT imaging systems for superior anatomical localization in oncology diagnostics
  • 5.5. Growing demand for personalized dosimetry protocols in radiopharmaceutical therapy planning based on quantitative SPECT metrics
  • 5.6. Regulatory approvals of new 99mTc-labeled myocardial perfusion agents for improved chronic coronary disease management
  • 5.7. Implementation of cloud-based SPECT data management platforms for enhanced multicenter collaboration and telemedicine analyses
  • 5.8. Advancements in solid-state detector technologies to boost sensitivity and spatial resolution of next-generation SPECT cameras
  • 5.9. Increasing adoption of standardized quantification software for reproducible longitudinal monitoring of Parkinson's disease progression via SPECT
  • 5.10. Surge in clinical studies evaluating PSMA-targeted radiotracers for prostate cancer staging using SPECT molecular imaging modalities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single Photon Emission Computed Tomography Market, by Detector

  • 8.1. Czt
  • 8.2. Nai Scintillation
  • 8.3. Solid State
    • 8.3.1. Germanium Semiconductor
    • 8.3.2. Silicon Photomultiplier

9. Single Photon Emission Computed Tomography Market, by End User

  • 9.1. Diagnostic Centers
  • 9.2. Hospitals
    • 9.2.1. Private Hospitals
    • 9.2.2. Public Hospitals
  • 9.3. Research Institutes

10. Single Photon Emission Computed Tomography Market, by Product

  • 10.1. Dual Head
  • 10.2. Single Head
  • 10.3. Triple Head

11. Single Photon Emission Computed Tomography Market, by Application

  • 11.1. Cardiology
  • 11.2. Neurology
  • 11.3. Oncology

12. Single Photon Emission Computed Tomography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Single Photon Emission Computed Tomography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Single Photon Emission Computed Tomography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. GE HealthCare Technologies Inc.
    • 15.3.2. Siemens Healthineers AG
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. Spectrum Dynamics Medical Ltd.
    • 15.3.6. Digirad Corporation
    • 15.3.7. Neusoft Medical Systems Co., Ltd.
    • 15.3.8. Mediso Medical Imaging Systems Ltd.
    • 15.3.9. Shimadzu Corporation
    • 15.3.10. Hitachi, Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 246. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 247. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 248. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 249. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 252. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 253. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 274. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 275. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 276. BRICS SINGLE